R Dorent

Author PubWeight™ 38.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Plasma levels of thrombomodulin in pulmonary hypertension. Am J Med 1996 2.10
2 Pacemaker infective endocarditis. Am J Cardiol 1998 1.62
3 Video-thoracoscopic pericardial window in the diagnosis and treatment of pericardial effusions. Am J Cardiol 1998 1.55
4 Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 1998 1.49
5 Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survival. Gastroenterology 2000 1.47
6 Dynamic cardiomyoplasty: effect of discontinuing latissimus dorsi muscle stimulation on left ventricular systolic and diastolic performance and exercise capacity. J Am Coll Cardiol 1995 1.39
7 Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders. J Clin Oncol 2001 1.35
8 Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000 1.18
9 Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998 1.14
10 Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center. J Clin Oncol 1995 1.13
11 Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol 1999 1.09
12 Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 1997 1.07
13 Endothelin-1 in pulmonary hypertension. N Engl J Med 1993 0.95
14 Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Eur J Heart Fail 1999 0.94
15 Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol 1993 0.94
16 Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group. Eur Heart J 1999 0.90
17 Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus. Hepatology 1999 0.90
18 Results of subtotal pericardiectomy for constrictive pericarditis. Eur J Cardiothorac Surg 1993 0.87
19 Heart retransplantation: a 23-year single-center clinical experience. Ann Thorac Surg 1998 0.86
20 Apoptosis and expression of heme oxygenase-1 in heart transplant recipients during acute rejection episode. Transplant Proc 2002 0.85
21 [Etiologic course of heart valve diseases surgically treated during 20 years in France]. Arch Mal Coeur Vaiss 1992 0.84
22 Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases. Rev Rhum Engl Ed 1995 0.83
23 Biliary surgery after heart transplantation. Am J Surg 1998 0.83
24 The role of percutaneous transluminal coronary angioplasty in heart transplant recipients. J Heart Lung Transplant 2000 0.81
25 Aetiology of surgically treated mitral regurgitation. Eur Heart J 1991 0.80
26 Safety, tolerability, and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil-based formulation of cyclosporine--results at 24 months after transplantation. Transplantation 2001 0.79
27 [Chronic constrictive pericarditis. A retrospective study of a series of 84 patients]. Arch Mal Coeur Vaiss 1994 0.79
28 High prevalence of antiphospholipid antibodies in precapillary pulmonary hypertension. J Rheumatol 1996 0.79
29 European multicenter tacrolimus heart pilot study: three year follow-up. J Heart Lung Transplant 2001 0.79
30 Clinical features and contribution of virological findings to the management of Kaposi sarcoma in organ-allograft recipients. Arch Dermatol 2000 0.78
31 La Pitié heart transplantation: 30-year single center clinical experience. Clin Transpl 1998 0.78
32 Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression. Mol Pharmacol 2008 0.78
33 Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine--results at six months after transplantation. Transplantation 1999 0.78
34 How to manage patients with severe left ventricular dysfunction and valvular regurgitation. J Heart Valve Dis 1996 0.78
35 European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results--European Tacrolimus Multicenter Heart Study Group. J Heart Lung Transplant 1998 0.78
36 [Cholelithiasis in heart transplant patients]. Ann Chir 2000 0.78
37 Apoptosis and expression of heme oxygenase-1 in heart transplant recipients during acute rejection episodes. Transplant Proc 2002 0.77
38 Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study. Heart 2001 0.77
39 Plasma endothelin and pulmonary pressures in patients with congestive heart failure. Am Heart J 1993 0.76
40 Thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992 0.75
41 [Endothelin: the vasoconstrictor of the 1990's?]. Rev Med Interne 1993 0.75
42 Posttransplantation cytotoxic immunoglobulin G is associated with a high rate of acute allograft dysfunctions in heart transplant recipients. Am Heart J 1999 0.75
43 Detection of prosthetic valve thrombosis using 111indium platelet imaging. Eur Heart J 1990 0.75
44 Heart transplantation: update. Clin Transpl 1992 0.75
45 Cyclosporin A-mediated cholestasis in patients with chronic hepatitis after heart transplantation. Eur J Gastroenterol Hepatol 1996 0.75
46 Heart and lung transplantation: La Pitié experience. Transplant Proc 1997 0.75
47 Heart transplant for the failing ischaemic ventricle. Cardiovasc Surg 1996 0.75
48 Analysis of well-being after organ transplantation in a large cohort of French patients. Transplant Proc 2002 0.75
49 [Long-term results of surgical valvuloplasty for non-ischemic mitral insufficiency. Apropos of 155 cases]. Ann Med Interne (Paris) 1991 0.75
50 [Long term results of the surgical treatment of obstructive hypertrophic cardiomyopathies]. Arch Mal Coeur Vaiss 1996 0.75
51 Long-term results of mitral valve repair for non-ischaemic mitral regurgitation. Eur Heart J 1991 0.75
52 Patient to patient hepatitis B transmission during heart biopsy procedures. A report of the European Working Party on Viral Hepatitis in Heart Transplant Recipients. J Hosp Infect 1996 0.75
53 [Immediate and long-term results of coronary surgery under age 40]. Arch Mal Coeur Vaiss 1992 0.75
54 Position-related factors in mitral and tricuspid bioprostheses degenerative changes. J Cardiovasc Surg (Torino) 1997 0.75
55 Heart transplantation in 1992: the La Pitié experience. Transplant Proc 1993 0.75
56 Study of bone mineral density after cardiac transplantation. Transplant Proc 1995 0.75
57 [High prevalence of hepatitis B after heart transplantation: absence of evidence for transfusional transmission]. Gastroenterol Clin Biol 1992 0.75
58 Long-term survival of heart transplant recipients with lung cancer: the role of chest computed tomography screening. Thorac Cardiovasc Surg 2007 0.75
59 [Tricuspid valve replacements in adults. Long-term results]. Arch Mal Coeur Vaiss 1993 0.75
60 [Coronary reperfusion. Can the myocardium and lives be saved by coronary reperfusion treatment?]. Rev Prat 1987 0.75
61 [Alcoholic cardiomyopathy and heart transplantation]. Arch Mal Coeur Vaiss 1998 0.75
62 Coronary artery vasomotion in cardiac transplant patients with normal coronary angiograms. Int J Cardiol 1993 0.75
63 Effect of cryopreservation on endothelin-1 productions of human mammary artery. Thromb Res 2000 0.75
64 [Infectious complications of heart-lung transplantation]. Agressologie 1992 0.75
65 Influence of HLA matching on graft survival and incidence and severity of graft rejection in cardiac transplantation. Transplant Proc 1994 0.75
66 [Hemorrhagic risk in intravenously administered thrombolytic treatment in acute myocardial infarction]. Arch Mal Coeur Vaiss 1988 0.75
67 [Acute cardiac graft rejection after orthotopic cardiac transplantation. Elements of diagnosis and monitoring, therapeutic attitude]. Therapie 1993 0.75
68 Extra-annular procedures in the surgical management of prosthetic valve endocarditis. Eur Heart J 1995 0.75
69 [Cardiac transplantation. Lack of donor organs. Current status]. Arch Mal Coeur Vaiss 1996 0.75
70 [Cardiac transplantation in 1997]. Ann Cardiol Angeiol (Paris) 1997 0.75
71 Pulmonary hypertension and dexfenfluramine. Eur J Clin Pharmacol 1995 0.75
72 [Value of the protein profile in the diagnosis of infectious endocarditis when hemolysis is present]. Rev Med Interne 2002 0.75
73 Hematoma of the interventricular septum following right ventricular endomyocardial biopsy for the detection of allograft rejection after heart transplantation. J Heart Lung Transplant 1999 0.75
74 [Reoperation for aortic valve replacement after myocardial revascularization]. Arch Mal Coeur Vaiss 1996 0.75
75 Influence of arterial allograft preparation techniques on chronic vascular rejection: a histological study. Transplant Proc 1996 0.75
76 An immunological score for prediction of acute rejection of heart transplants. Transplant Proc 1995 0.75
77 [Study of the etiologic mechanism of valvular regurgitation using Doppler echography]. Arch Mal Coeur Vaiss 1990 0.75
78 [Video-surgery for pericardial effusion. Technique and results]. Arch Mal Coeur Vaiss 1996 0.75